Vincent A. de Weger

A phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours

Maja J.A. de Jonge, Vincent A. de Weger, Mark A. Dickson et al. · European Journal of Cancer · 2017 · 126 citations

Medicine, Oncology, Pharmacology +8

A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours

Vincent A. de Weger, Maja J.A. de Jonge, Marlies H.G. Langenberg et al. · British Journal of Cancer · 2018 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer

Vincent A. de Weger, Annelies W. Turksma, Quirinus J.M. Voorham et al. · Clinical Cancer Research · 2011 · 67 citations

Medicine, Immunology, Oncology +16

Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy

Annelies W. Turksma, Veerle M.H. Coupé, Marc C. Shamier et al. · Clinical Cancer Research · 2015 · 52 citations

Medicine, Immunology, Oncology +17

Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial

Charlotte W. Duinkerken, Vincent A. de Weger, Wouter A. Dreschler et al. · Otology & Neurotology · 2021 · 26 citations · Full text

Medicine, Otolaryngology, Pharmacology +17